- Home
- KRUS vs MGTX Comparison
KRUS vs MGTX Comparison
Compare KRUS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRUS | MGTX |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 649.3M | 744.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRUS | MGTX |
|---|---|---|
| Price | $51.89 | $9.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $84.29 | $23.83 |
| AVG Volume (30 Days) | 329.7K | ★ 602.7K |
| Earning Date | 01-06-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $282,763,000.00 | $27,417,000.00 |
| Revenue This Year | $19.06 | N/A |
| Revenue Next Year | $20.14 | $619.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.88 | ★ 96.83 |
| 52 Week Low | $40.03 | $4.55 |
| 52 Week High | $106.60 | $9.73 |
Technical Indicators
Market Signals| Indicator | KRUS | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 62.72 |
| Support Level | $52.69 | $8.25 |
| Resistance Level | $55.50 | $9.13 |
| Average True Range (ATR) | 2.43 | 0.51 |
| MACD | 1.00 | 0.11 |
| Stochastic Oscillator | 69.59 | 77.62 |
Price Performance
Historical ComparisonAbout KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.